Market Introduction
Polymerase chain reaction (PCR) is used for accurate point-of-care diagnostics that help rapidly identify and determine the cause of respiratory tract infections. In addition, PCR is generally preferred in inpatient and outpatient settings, which has helped improve the market's growth in recent years. The current outbreak of SARS CoV2 is boosting the growth of the market.
Market Overview and Dynamics
The Europe PCR for respiratory infection diagnostics market is expected to reach US$ 2,432.46 million by 2028 from US$ 1,241.01 million in 2021. The market is anticipated to grow at a CAGR of 10.1% from 2021 to 2028. Increasing burden of chronic respiratory diseases (CRDs) and growing developments for PCR testing are expected to propel the growth of the market. However, availability of alternative assays is the major factor hindering the market growth.
Key Market Segments
In terms of type, the qPCR segment accounted for the highest share, and it is expected to dominate the largest market share in the coming future. The segment’s growth is majorly driven by its properties such as enormous dynamic range, remarkable sensitivity, ability to be very sequence-specific, little to no post-amplification processing, and increased sample throughput. Also, the regular developments for the PCR type are driving market.
Major Sources and Companies Listed
European Centre for Disease Prevention and Control, European Medicines Agency, European Respiratory Society, and Food and Drug Administration are among the major secondary sources for the Europe PCR for respiratory infection diagnostics market included in the report.
Reasons to Buy Report
Europe PCR for Respiratory Infection Diagnostics Market Segmentation
by Type
by Product Type
by Infection Type
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 1,241.01 Million |
| Market Size by 2028 | US$ 2,432.46 Million |
| CAGR (2021 - 2028) | 10.1% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Type
|
| Regions and Countries Covered |
Europe
|
| Market leaders and key company profiles |
|
The Europe PCR for Respiratory Infection Diagnostics Market is valued at US$ 1,241.01 Million in 2021, it is projected to reach US$ 2,432.46 Million by 2028.
As per our report Europe PCR for Respiratory Infection Diagnostics Market, the market size is valued at US$ 1,241.01 Million in 2021, projecting it to reach US$ 2,432.46 Million by 2028. This translates to a CAGR of approximately 10.1% during the forecast period.
The Europe PCR for Respiratory Infection Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe PCR for Respiratory Infection Diagnostics Market report:
The Europe PCR for Respiratory Infection Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe PCR for Respiratory Infection Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe PCR for Respiratory Infection Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe PCR for Respiratory Infection Diagnostics Market
